American Century Companies’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-232,356
| Closed | -$495K | – | 2886 |
|
|
2024
Q4 | $495K | Buy |
232,356
+32,935
| +17% | +$70.2K | ﹤0.01% | 2509 |
|
|
2024
Q3 | $558K | Buy |
199,421
+35,882
| +22% | +$100K | ﹤0.01% | 2440 |
|
|
2024
Q2 | $381K | Buy |
163,539
+39,498
| +32% | +$92K | ﹤0.01% | 2535 |
|
|
2024
Q1 | $554K | Buy |
124,041
+45,894
| +59% | +$205K | ﹤0.01% | 2416 |
|
|
2023
Q4 | $251K | Buy |
78,147
+22,611
| +41% | +$72.6K | ﹤0.01% | 2627 |
|
|
2023
Q3 | $176K | Buy |
55,536
+12,380
| +29% | +$39.2K | ﹤0.01% | 2628 |
|
|
2023
Q2 | $214K | Buy |
43,156
+16,664
| +63% | +$82.8K | ﹤0.01% | 2510 |
|
|
2023
Q1 | $132K | Buy |
26,492
+4,467
| +20% | +$22.2K | ﹤0.01% | 2500 |
|
|
2022
Q4 | $139K | Buy |
22,025
+5,028
| +30% | +$31.6K | ﹤0.01% | 2406 |
|
|
2022
Q3 | $184K | Buy |
+16,997
| New | +$184K | ﹤0.01% | 2241 |
|